357 related articles for article (PubMed ID: 31990231)
21. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
22. Can intrauterine contraceptive devices lead to VulvoVaginal Candidiasis (VVC) and Anemia in Iranian new users?
Behboudi-Gandevani S; Imani S; Moghaddam-Banaem L; Roudbar-Mohammadi S
Sex Reprod Healthc; 2015 Mar; 6(1):40-3. PubMed ID: 25637424
[TBL] [Abstract][Full Text] [Related]
23. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
24. Can intrauterine contraceptive devices be a Candida albicans reservoir?
Chassot F; Negri MF; Svidzinski AE; Donatti L; Peralta RM; Svidzinski TI; Consolaro ME
Contraception; 2008 May; 77(5):355-9. PubMed ID: 18402852
[TBL] [Abstract][Full Text] [Related]
25. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Dhar R; AlFouzan W; Yusef H; El Chaar M
BMC Infect Dis; 2020 Jan; 20(1):32. PubMed ID: 31931738
[TBL] [Abstract][Full Text] [Related]
27. Detection of phospholipase activity of Candida albicans and non albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area.
Fule SR; Das D; Fule RP
Indian J Med Microbiol; 2015; 33(1):92-5. PubMed ID: 25560009
[TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
29. Phospholipase and Aspartyl Proteinase Activities of Candida Species Causing Vulvovaginal Candidiasis in Patients with Type 2 Diabetes Mellitus.
Bassyouni RH; Wegdan AA; Abdelmoneim A; Said W; AboElnaga F
J Microbiol Biotechnol; 2015 Oct; 25(10):1734-41. PubMed ID: 26032358
[TBL] [Abstract][Full Text] [Related]
30. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
31. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression.
Zhang JY; Liu JH; Liu FD; Xia YH; Wang J; Liu X; Zhang ZQ; Zhu N; Yan-Yan ; Ying Y; Huang XT
Mycoses; 2014 Oct; 57(10):584-91. PubMed ID: 24962255
[TBL] [Abstract][Full Text] [Related]
32. Changing virulence factors among vaginal non-
Kalaiarasan K; Singh R; Chaturvedula L
Indian J Med Microbiol; 2018; 36(3):364-368. PubMed ID: 30429388
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract.
Sharifzadeh A; Soltani M; Shokri H
Mycoses; 2015 Aug; 58(8):478-84. PubMed ID: 26152466
[TBL] [Abstract][Full Text] [Related]
34. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
35. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China.
Shi XY; Yang YP; Zhang Y; Li W; Wang JD; Huang WM; Fan YM
J Med Microbiol; 2015 Apr; 64(Pt 4):390-393. PubMed ID: 25596116
[TBL] [Abstract][Full Text] [Related]
36. Effect of intrauterine device insertion on Candida species in cervicovaginal specimen identified by polymerase chain reaction technic: A longitudinal study on Iranian women.
Moradi R; Shariat M; Moghaddam-Banaem L
J Obstet Gynaecol Res; 2019 Feb; 45(2):438-442. PubMed ID: 30426620
[TBL] [Abstract][Full Text] [Related]
37. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
Nagashima M; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
[TBL] [Abstract][Full Text] [Related]
38. Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis.
Zhu YX; Shi Y; Fan SR; Liu XP; Yang J; Zhong SL
BMC Infect Dis; 2019 May; 19(1):461. PubMed ID: 31117966
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
40. A comparative study on production of extracellular hydrolytic enzymes of Candida species isolated from patients with surgical site infection and from healthy individuals and their co-relation with antifungal drug resistance.
Erum R; Samad F; Khan A; Kazmi SU
BMC Microbiol; 2020 Dec; 20(1):368. PubMed ID: 33272216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
